Results for tag: "Spatial Transcriptomics"

Spatial transcriptomics is an emerging field within biotechnology that combines histological techniques with high-throughput RNA-sequencing. This approach enables researchers to measure gene expression patterns and visualize how cells operate within their native tissue contexts, providing insights into the complexity of biological systems. Innovation in this field is driven by the need to understand the spatial heterogeneity of tissues, which is crucial for unraveling the underlying mechanisms of diseases and developing targeted therapies. The market for spatial transcriptomics is characterized by the presence of both established biotechnology companies and specialized startups that focus on delivering comprehensive systems to map and quantify gene expression in tissue samples. These technologies cater to various applications, including oncology, neuroscience, and developmental biology. Customers for spatial transcriptomics platforms are typically research laboratories, academic institutions, and pharmaceutical companies that seek to enhance their understanding of molecular biology on a spatial scale. Some notable players in the spatial transcriptomics market are 10x Genomics, which offers instruments and consumables for spatially resolved transcriptomic analyses; NanoString Technologies, known for its nCounter system and GeoMx Digital Spatial Profiler; and Illumina, a recognized leader in genomics that has also ventured into spatial transcriptomics through partnerships and product development. Additional companies contributing to the spatial transcriptomics landscape are Spatial Transcriptomics AB, acquired by 10x Genomics, and ReadCoor, which is advancing its Fluorescent in situ Sequencing (FISSEQ) technology. Show Less Read more